Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 19/20 | 0.86 |
| ▸ | FKBP5 | Q13451 | 8/20 | 0.86 |
| ▸ | FKBP4 | Q02790 | 7/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31548587 | 1.00 | FKBP1A (0.86) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL18086951 | 1.00 | FKBP1A (0.86) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL16298862 | 1.00 | FKBP1A (0.86) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL18089279 | 0.95 | FKBP1A (0.89) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL16683539 | 0.95 | FKBP1A (0.89) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL13694681 | 0.93 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL619873 | 0.93 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL10034617 | 0.93 | FKBP1A (0.90) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL619874 | 0.93 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL12807412 | 0.93 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594275-B2 | Immunophilin binding agents and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-07 | — | — | US | disclosed |
| US-20230063768-A1 | IMMUNOPHILIN BINDING AGENTS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230063768-A1 | IMMUNOPHILIN BINDING AGENTS AND USES THEREOF | PMP22, MAG, FABP7 | FKBP1A 320/4885FKBP5 618/4885FKBP4 424/4885 |
| US-12594275-B2 | Immunophilin binding agents and uses thereof | CCR1, CCRL2, CCR3 | FKBP1A 1251/4885FKBP5 2845/4885FKBP4 2318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.